HPV-transgenic mouse models: Tools for studying the cancer-associated immune response

Virus Res. 2017 May 2:235:49-57. doi: 10.1016/j.virusres.2017.04.001. Epub 2017 Apr 3.

Abstract

For decades, research on the pathogenesis of papillomavirus-induced lesions, particularly of human papillomavirus (HPV) has relied on the use of animal models. Among these, HPV-transgenic mice are some of the most frequently employed. After some initial unsuccessful attempts, researchers have succeeded in targeting the expression of one or more HPV-16 oncogenes to squamous epithelia, closely mimicking the lesions observed in cancer patients. The present review describes the relevance and usefulness of these animal models in understanding the tumour-associated immune response and developing new preventive and therapeutic strategies for HPV-associated cancers. In particular, this review details the importance of transgenic mice for dissecting and modulating relevant aspects of the tumour-associated immune response. Other animal models for studying papillomaviral diseases are briefly mentioned, along with their respective advantages and limitations. HPV-transgenic mouse strains remain reliable, versatile and commodious, even if perhaps underestimated, animal models for studying HPV-induced multi-step carcinogenesis.

Keywords: Carcinogenesis; Human papillomavirus; Immune response; Transgenic mouse models.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal*
  • Mice
  • Mice, Transgenic*
  • Neoplasms / immunology*
  • Neoplasms / pathology*
  • Papillomaviridae / genetics*